|
Rapid mRNA-Display Selection of an IL-6 Inhibitor Using Continuous-Flow Magnetic Separation
|
journal
|
July 2011 |
|
Contribution of Variable Domains to the Stability of Humanized IgG1 Monoclonal Antibodies
|
journal
|
April 2008 |
|
UCSF ChimeraX: Meeting modern challenges in visualization and analysis: UCSF ChimeraX Visualization System
|
journal
|
September 2017 |
|
Characterization of neutralizing monoclonal antibodies recognizing a 15-residues epitope on the spike protein HR2 region of severe acute respiratory syndrome coronavirus (SARS-CoV)
|
journal
|
August 2005 |
|
mRNA display: ligand discovery, interaction analysis and beyond
|
journal
|
March 2003 |
|
Unexpected Receptor Functional Mimicry Elucidates Activation of Coronavirus Fusion
|
journal
|
February 2019 |
|
SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor
|
journal
|
April 2020 |
|
Structure, Function, and Antigenicity of the SARS-CoV-2 Spike Glycoprotein
|
journal
|
April 2020 |
|
Potent Neutralizing Antibodies against SARS-CoV-2 Identified by High-Throughput Single-Cell Sequencing of Convalescent Patients’ B Cells
|
journal
|
July 2020 |
|
Structures of Human Antibodies Bound to SARS-CoV-2 Spike Reveal Common Epitopes and Recurrent Features of Antibodies
|
journal
|
August 2020 |
|
Deep Mutational Scanning of SARS-CoV-2 Receptor Binding Domain Reveals Constraints on Folding and ACE2 Binding
|
journal
|
September 2020 |
|
Structural and Functional Analysis of the D614G SARS-CoV-2 Spike Protein Variant
|
journal
|
October 2020 |
|
Mapping Neutralizing and Immunodominant Sites on the SARS-CoV-2 Spike Receptor-Binding Domain by Structure-Guided High-Resolution Serology
|
journal
|
November 2020 |
|
The antigenic anatomy of SARS-CoV-2 receptor binding domain
|
journal
|
April 2021 |
|
N-terminal domain antigenic mapping reveals a site of vulnerability for SARS-CoV-2
|
journal
|
April 2021 |
|
Neutralizing and protective human monoclonal antibodies recognizing the N-terminal domain of the SARS-CoV-2 spike protein
|
journal
|
April 2021 |
|
Transmission, infectivity, and neutralization of a spike L452R SARS-CoV-2 variant
|
journal
|
June 2021 |
|
Neutralization of SARS-CoV-2 by Destruction of the Prefusion Spike
|
journal
|
September 2020 |
|
Complete Mapping of Mutations to the SARS-CoV-2 Spike Receptor-Binding Domain that Escape Antibody Recognition
|
journal
|
January 2021 |
|
Potent SARS-CoV-2 neutralizing antibodies directed against spike N-terminal domain target a single supersite
|
journal
|
May 2021 |
|
SARS-CoV-2 spike variants exhibit differential infectivity and neutralization resistance to convalescent or post-vaccination sera
|
journal
|
April 2021 |
|
Inference of Macromolecular Assemblies from Crystalline State
|
journal
|
September 2007 |
|
Automated electron microscope tomography using robust prediction of specimen movements
|
journal
|
October 2005 |
|
High resolution single particle refinement in EMAN2.1
|
journal
|
May 2016 |
|
In Vitro Selection of Peptides and Proteins—Advantages of mRNA Display
|
journal
|
December 2019 |
|
mRNA Display Selection of a High-Affinity, Modification-Specific Phospho-IκBα-Binding Fibronectin
|
journal
|
July 2008 |
|
Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus
|
journal
|
November 2003 |
|
Cryo-electron microscopy structure of a coronavirus spike glycoprotein trimer
|
journal
|
February 2016 |
|
Pre-fusion structure of a human coronavirus spike protein
|
journal
|
March 2016 |
|
Cryo-EM structures of MERS-CoV and SARS-CoV spike glycoproteins reveal the dynamic receptor binding domains
|
journal
|
April 2017 |
|
cryoSPARC: algorithms for rapid unsupervised cryo-EM structure determination
|
journal
|
February 2017 |
|
Adapt or perish: SARS-CoV-2 antibody escape variants defined by deletions in the Spike N-terminal Domain
|
journal
|
April 2021 |
|
Mapping mutations to the SARS-CoV-2 RBD that escape binding by different classes of antibodies
|
journal
|
July 2021 |
|
A pneumonia outbreak associated with a new coronavirus of probable bat origin
|
journal
|
February 2020 |
|
Cross-neutralization of SARS-CoV-2 by a human monoclonal SARS-CoV antibody
|
journal
|
May 2020 |
|
Convergent antibody responses to SARS-CoV-2 in convalescent individuals
|
journal
|
June 2020 |
|
Potently neutralizing and protective human antibodies against SARS-CoV-2
|
journal
|
July 2020 |
|
Potent neutralizing antibodies against multiple epitopes on SARS-CoV-2 spike
|
journal
|
July 2020 |
|
SARS-CoV-2 neutralizing antibody structures inform therapeutic strategies
|
journal
|
October 2020 |
|
Spike mutation D614G alters SARS-CoV-2 fitness
|
journal
|
October 2020 |
|
Antibody resistance of SARS-CoV-2 variants B.1.351 and B.1.1.7
|
journal
|
March 2021 |
|
Detection of a SARS-CoV-2 variant of concern in South Africa
|
journal
|
March 2021 |
|
Escape of SARS-CoV-2 501Y.V2 from neutralization by convalescent plasma
|
journal
|
March 2021 |
|
Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein
|
journal
|
July 2020 |
|
SARS-CoV-2 and bat RaTG13 spike glycoprotein structures inform on virus evolution and furin-cleavage effects
|
journal
|
July 2020 |
|
REGN-COV2, a Neutralizing Antibody Cocktail, in Outpatients with Covid-19
|
journal
|
January 2021 |
|
Biophysical properties of the clinical-stage antibody landscape
|
journal
|
January 2017 |
|
Immunogenicity and structures of a rationally designed prefusion MERS-CoV spike antigen
|
journal
|
August 2017 |
|
A complete library of point substitution mutations in the glucocorticoid response element of mouse mammary tumor virus.
|
journal
|
February 1986 |
|
RNA-peptide fusions for the in vitro selection of peptides and proteins
|
journal
|
November 1997 |
|
mRNA Display Design of Fibronectin-based Intrabodies That Detect and Inhibit Severe Acute Respiratory Syndrome Coronavirus Nucleocapsid Protein
|
journal
|
June 2009 |
|
Phaser crystallographic software
|
journal
|
July 2007 |
|
XDS
|
journal
|
January 2010 |
|
PHENIX: a comprehensive Python-based system for macromolecular structure solution
|
journal
|
January 2010 |
|
Features and development of Coot
|
journal
|
March 2010 |
|
Overview of the CCP 4 suite and current developments
|
journal
|
March 2011 |
|
Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation
|
journal
|
February 2020 |
|
Potent neutralizing antibodies from COVID-19 patients define multiple targets of vulnerability
|
journal
|
June 2020 |
|
Broad neutralization of SARS-related viruses by human monoclonal antibodies
|
journal
|
June 2020 |
|
Studies in humanized mice and convalescent humans yield a SARS-CoV-2 antibody cocktail
|
journal
|
June 2020 |
|
Antibody cocktail to SARS-CoV-2 spike protein prevents rapid mutational escape seen with individual antibodies
|
journal
|
June 2020 |
|
Structural basis of a shared antibody response to SARS-CoV-2
|
journal
|
July 2020 |
|
Mosaic nanoparticles elicit cross-reactive immune responses to zoonotic coronaviruses in mice
|
journal
|
February 2021 |
|
Recurrent deletions in the SARS-CoV-2 spike glycoprotein drive antibody escape
|
journal
|
February 2021 |
|
Prospective mapping of viral mutations that escape antibodies used to treat COVID-19
|
journal
|
January 2021 |
|
Estimated transmissibility and impact of SARS-CoV-2 lineage B.1.1.7 in England
|
journal
|
March 2021 |
|
Structural and functional ramifications of antigenic drift in recent SARS-CoV-2 variants
|
journal
|
August 2021 |
|
SARS-CoV-2 immune evasion by the B.1.427/B.1.429 variant of concern
|
journal
|
July 2021 |
|
The neutralizing antibody, LY-CoV555, protects against SARS-CoV-2 infection in nonhuman primates
|
journal
|
May 2021 |
|
Monoclonal Antibodies Targeting the HR2 Domain and the Region Immediately Upstream of the HR2 of the S Protein Neutralize In Vitro Infection of Severe Acute Respiratory Syndrome Coronavirus
|
journal
|
January 2006 |
|
Human Monoclonal Antibodies against Highly Conserved HR1 and HR2 Domains of the SARS-CoV Spike Protein Are More Broadly Neutralizing
|
journal
|
November 2012 |
|
Protocol and Reagents for Pseudotyping Lentiviral Particles with SARS-CoV-2 Spike Protein for Neutralization Assays
|
journal
|
May 2020 |
|
New tools for automated high-resolution cryo-EM structure determination in RELION-3
|
journal
|
November 2018 |
|
The human coronavirus HCoV-229E S-protein structure and receptor binding
|
journal
|
October 2019 |
|
Escape from neutralizing antibodies by SARS-CoV-2 spike protein variants
|
journal
|
October 2020 |